IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens

Aim. Eradication of hepatitis C virus (HCV) is still challenging even if interferon- (IFN-) free regimens with direct-acting antiviral agents (DAAs) for HCV-infected individuals are available in clinical practice. IFNL4 is a newly described protein, associated with human antiviral defenses. We inves...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Hepatol
Egile Nagusiak: Miyamura, Tatsuo, Kanda, Tatsuo, Nakamoto, Shingo, Arai, Makoto, Nakamura, Masato, Wu, Shuang, Jiang, Xia, Sasaki, Reina, Haga, Yuki, Yasui, Shin, Ooka, Yoshihiko, Chiba, Tetsuhiro, Imazeki, Fumio, Mikami, Shigeru, Yokosuka, Osamu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274707/
https://ncbi.nlm.nih.gov/pubmed/25548683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/723868
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak